Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease

Hepato-Gastroenterology

Volumn 46, Issue 26, 1999, Pages 920-923

  Griga, Thomas ^a   Voigt, Edgar ^b   Gretzer, Britta ^b   Brasch, Frank ^b   May, Burkard ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NONE

Author keywords

Inflammatory bowel disease; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; BIOPSY; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; CULTURE TECHNIQUES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTESTINAL MUCOSA; LYMPHOKINES; MALE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032928383     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 1 Ferrara N, Henzel WJ: Biochem. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biophys Res Commun 1989; 161:851.
2. 2 Senger DR: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983.
3. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991; 138:213-221.
4. 4 Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR: Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995; 107:233-235.
5. 5 Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995; 55:3964-3968.
6. 6 Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993; 53:4727-4735.
7. 7 Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176:1375-1379.
8. 8 Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 20:12607-12613.
9. 9 Burke PA, Lehmann BK, Powell JS: Vascular endothelial growth factor causes endothelial cell proliferation after vascular injury. Biochem Biophys Res Commun 1995; 207:348-354.
10. 10 Peters K, de Vries C, Williams L: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci 1993; 90:8915-8919.
11. 11 Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van De Water L: Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial receptors in delayed hypersensitivity skin reactions. J Immunol 1995; 154:2801-2807.
12. 12 Ferrara N: Vascular endothelial growth factor - The trigger for neovascularization in the eye. Lab Invest 1995; 72:615-618. (Editorial)
13. 13 Liu Y, Cox SR, Morita T, Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res 1995; 77:638-643.
14. 14 Minchenko A, Bauer T, Salceda S, Caro J: Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994; 71:374-379.
15. 15 Fava RA, Olsen NJ, Spencer-Green G, Yeo TK, Yeo KT, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid arthritis. J Exp Med 1994; 180:340-346.
16. 16 Koch E, Harlow I, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N: Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152:4149-4155.
17. 17 Brown LF, Harris TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, Detmar M: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis and erythema multiforme. J Invest Dermatol 1995; 104:744-749.
18. 18 Schurer-Maly CC, Fried M, Maly FE, Binek J, Frenzer A: Vascular endothelial growth factor in serum of patients with inflammatory bowel disease. Scand J Gastroenterol 1997; 32:959-960.
19. 19 Griga T, Tromm A, Spranger J, May B: Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33:504-508.
20. 20 Griga T, Gutzeit A, Sommerkamp K, May B: Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Europ J Gastroenterol Hepatol 1999. (In press)
21. 21 Best WR, Becktel JM, Singleton JW, Kern F: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterol 1976; 70:439-444.
22. 22 Truelove SC, Witts LJ: Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955; 2:1041-1044.
23. 23 Morson BC, Dawson IMP: Gastro-intestinal pathology. Oxford Blackwell 1979; pp. 551-562.
24. 24 Roberts W, Palade G: Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Science 1995; 108:2369-2379.
25. 25 Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991; 181:902-906.
26. 26 Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993; 265:h586-592.
27. 27 Xie Q, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256:225-228.
28. 28 Ignarro LJ: Biosynthesis and metabolism of endothelium derived nitric oxide. Annu Rev Pharmacol Toxicol 1990; 30:535-560.
29. 29 Rachmilewitz D, Stamler JS, Karmeli F, Loscalzo J, Xavier RJ, Podolsky DK: Role of nitric oxide in the pathogenesis of IBD. In: Monteiro E, Veloso FT (Eds.). Inflammatory bowel diseases. New insights into mechanisms of inflammation and challenges in diagnosis and treatment. London: Kluwer Academic Publishers, 1995; pp. 53-60.
30. 30 Middleton SJ, Shorthouse M, Hunter JO: Increased nitric oxide synthase in ulcerative colitis. Lancet 1993; 341:465-466.